- Tytuł:
-
Development and internal validation of a clinical prediction model for individualized dosing of BAY 81-8973, A full-length recombinant
factor VIII , in pediatric patients with haemophilia A. - Autorzy:
- Źródło:
-
Thrombosis Research . Dec2023, Vol. 232, p6-14. 9p.
Czasopismo naukowe